MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...
An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS. Some patients experienced unprecedented functional recovery, offering new hope in a previously devastating diagnosis.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
For nearly a century, medical experts have known that individuals who suffer brain trauma, such as traumatic brain injury (TBI), are at an increased risk of developing dementia later in life.
Researchers have found a new method to distinguish between Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD) using vocal emotional expressions.
Researchers have found evidence suggesting that lifestyle factors may play a pivotal role in mitigating the risk of Alzheimer's disease, even among individuals carrying the ApoE4 gene variant.
Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?
Dr Nauf AlBendar, Doctor of Clinical Medicine & Founder of The Womb Effect, introduces spina bifida, the primary cause of foetal loss and substantial disabilities in newborns.
The secret of the genetic risk of schizophrenia has been hiding in plain sight — the placenta, says the groundbreaking study conducted by the Lieber Institute for Brain Development.
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
